Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.

Gene therapy offers great opportunities for the treatment of severe diseases including cancer. In recent years the design of synthetic carriers for nucleic acid delivery has become a research field of increasing interest. Studies on the delivery of plasmid DNA (pDNA) have brought up a variety of gene delivery vehicles. The more recently emerged gene silencing strategy by the intracellular delivery of small interfering RNA (siRNA) takes benefit from existing expertise in pDNA transfer. Despite common properties however, delivery of siRNA also faces distinct challenges due to apparent differences in size, stability of the formed nucleic acid complexes, the location and mechanism of action. This review emphasizes the common aspects and main differences between pDNA and siRNA delivery, taking into consideration a wide spectrum of polymer-based, lipidic and peptide carriers. Challenges and opportunities which result from these differences as well as the recent progress made in the optimization of carrier design are presented.

[1]  M. Buschmann,et al.  High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. , 2006, Biomaterials.

[2]  Xiaolan Chen,et al.  Chemical modification of gene silencing oligonucleotides for drug discovery and development. , 2005, Drug discovery today.

[3]  A S Verkman,et al.  Size-dependent DNA Mobility in Cytoplasm and Nucleus* , 2000, The Journal of Biological Chemistry.

[4]  Andrew D. Miller,et al.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. , 2004, Biochemistry.

[5]  A. J. Mixson,et al.  Highly branched HK peptides are effective carriers of siRNA , 2005, The journal of gene medicine.

[6]  Kevin Braeckmans,et al.  The transport of nanosized gene carriers unraveled by live-cell imaging. , 2006, Angewandte Chemie.

[7]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[8]  D. Schaffert,et al.  Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery. , 2011, Angewandte Chemie.

[9]  Yuichi Yamasaki,et al.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. , 2004, Journal of the American Chemical Society.

[10]  K. Mechtler,et al.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Sabine Boeckle,et al.  Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Kenneth A Howard,et al.  RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  M. Ogris,et al.  Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Yuichi Yamasaki,et al.  In situ single cell observation by fluorescence resonance energy transfer reveals fast intra‐cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine , 2004, The journal of gene medicine.

[15]  T. Cathomen,et al.  Targeted genome modifications using integrase-deficient lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[17]  L. J. Lee,et al.  Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Förster resonance energy transfer. , 2011, Molecular pharmaceutics.

[18]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Na Zhang,et al.  Cationic polymer optimization for efficient gene delivery. , 2010, Mini reviews in medicinal chemistry.

[20]  K. Leong,et al.  Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  T. Park,et al.  Dual gene targeted multimeric siRNA for combinatorial gene silencing. , 2011, Biomaterials.

[22]  M. Manoharan,et al.  RNAi therapeutics: a potential new class of pharmaceutical drugs , 2006, Nature chemical biology.

[23]  D. Schaffert,et al.  Poly(I:C)-Mediated Tumor Growth Suppression in EGF-Receptor Overexpressing Tumors Using EGF-Polyethylene Glycol-Linear Polyethylenimine as Carrier , 2011, Pharmaceutical Research.

[24]  Ling Peng,et al.  PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. , 2006, Chemical communications.

[25]  K Mechtler,et al.  The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. , 1994, The Journal of biological chemistry.

[26]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[27]  Leaf Huang,et al.  An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[28]  E. Wagner,et al.  Monomolecular assembly of siRNA and poly(ethylene glycol)-peptide copolymers. , 2008, Biomacromolecules.

[29]  K Mechtler,et al.  The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.

[30]  Yuhan Lee,et al.  Self-assembled siRNA-PLGA conjugate micelles for gene silencing. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[31]  A. Metspalu,et al.  Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo , 2011, Nucleic acids research.

[32]  M. Cotten,et al.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus , 2000, Gene Therapy.

[33]  P. Foster,et al.  Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? , 2007, American journal of respiratory cell and molecular biology.

[34]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[35]  Ű. Langel,et al.  Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[36]  C. Culmsee,et al.  Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer , 2004, The journal of gene medicine.

[37]  Leaf Huang,et al.  Nonviral methods for siRNA delivery. , 2009, Molecular pharmaceutics.

[38]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[39]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[40]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[41]  C. Pichon,et al.  Histidine-rich peptides and polymers for nucleic acids delivery. , 2001, Advanced drug delivery reviews.

[42]  N. Nishiyama,et al.  Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. , 2009, Biomacromolecules.

[43]  C. Bräuchle,et al.  Cellular dynamics of EGF receptor-targeted synthetic viruses. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  Lars J. Brandén,et al.  A peptide nucleic acid–nuclear localization signal fusion that mediates nuclear transport of DNA , 1999, Nature Biotechnology.

[45]  P. Lundin,et al.  A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  M. Wolfert,et al.  Chloroquine and amphipathic peptide helices show synergistic transfection in vitro , 1998, Gene Therapy.

[47]  E. Wagner,et al.  Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. , 2009, Bioconjugate chemistry.

[48]  S. Stass,et al.  Branched co-polymers of histidine and lysine are efficient carriers of plasmids. , 2001, Nucleic acids research.

[49]  D. Scherman,et al.  How to make siRNA lipoplexes efficient? Add a DNA cargo. , 2009, Biochimica et biophysica acta.

[50]  Yutaka Ikeda,et al.  Ligand-Targeted Delivery of Therapeutic siRNA , 2006, Pharmaceutical Research.

[51]  Yu Nie,et al.  Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[52]  P. Low,et al.  Ligand‐Targeted Delivery of Small Interfering RNAs to Malignant Cells and Tissues , 2009, Annals of the New York Academy of Sciences.

[53]  T. Tuschl,et al.  RNA Interference and Small Interfering RNAs , 2001, Chembiochem : a European journal of chemical biology.

[54]  D. Crommelin,et al.  An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems , 2005, The journal of gene medicine.

[55]  J. Lisziewicz,et al.  Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. , 2011, Vaccine.

[56]  N. Nishiyama,et al.  Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system. , 2010, Biomaterials.

[57]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Eccles,et al.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells , 2004, FEBS letters.

[59]  M. D. Brown,et al.  Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. , 2000, Bioconjugate chemistry.

[60]  M. Wood,et al.  Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[61]  T. Park,et al.  Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. , 2010, Nature materials.

[62]  E. Wagner,et al.  Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[63]  Wim E. Hennink,et al.  DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery , 2011, Pharmaceutical Research.

[64]  T. Minko,et al.  Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[65]  Xiao-Jin Yu,et al.  Transient gene expression by nonintegrating lentiviral vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[66]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Kjems,et al.  Surface functionalisation of PLGA nanoparticles for gene silencing. , 2010, Biomaterials.

[68]  Yu-Kyoung Oh,et al.  siRNA conjugate delivery systems. , 2009, Bioconjugate chemistry.

[69]  D. Lamm,et al.  Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. , 2008, The Journal of urology.

[70]  M. Ramezani,et al.  The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery , 2010, The journal of gene medicine.

[71]  Udo Bakowsky,et al.  Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. , 2010, Biomaterials.

[72]  F. Szoka,et al.  Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. , 1996, Biochemistry.

[73]  D. Scherman,et al.  Synthesis of poly(propylene glycol)-block-polyethylenimine triblock copolymers for the delivery of nucleic acids. , 2011, Macromolecular Bioscience.

[74]  C. I. Smith,et al.  PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation , 2011, Nucleic acids research.

[75]  Y. Bae,et al.  Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide. , 2011, Biomaterials.

[76]  M. Peng,et al.  Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. , 2011, International journal of pharmaceutics.

[77]  Y. Lim,et al.  Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. , 2003, Bioconjugate chemistry.

[78]  V. Lanzov.  Gene targeting for gene therapy: prospects. , 1999, Molecular genetics and metabolism.

[79]  Marie C. M. Lin,et al.  Revisit complexation between DNA and polyethylenimine - Effect of uncomplexed chains free in the solution mixture on gene transfection. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Ijeoma F. Uchegbu,et al.  The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer Agents , 2002, Pharmaceutical Research.

[81]  D. Schaffert,et al.  Gene therapy progress and prospects: synthetic polymer-based systems , 2008, Gene Therapy.

[82]  S. Betigeri,et al.  Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. , 2008, Bioconjugate chemistry.

[83]  T. Rana,et al.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.

[84]  O. Danos,et al.  Dilution of reporter gene with stuffer DNA does not alter the transfection efficiency of polyethylenimines , 2005, The journal of gene medicine.

[85]  P. Cullis,et al.  Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.

[86]  A. Aigner,et al.  PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy , 2008, Journal of drug targeting.

[87]  Ernst Wagner,et al.  Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[88]  Young Jik Kwon,et al.  Efficient and targeted delivery of siRNA in vivo , 2010, The FEBS journal.

[89]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[90]  E. Weiss,et al.  Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. , 2010, Bioconjugate chemistry.

[91]  Zheng-Rong Lu,et al.  New amphiphilic carriers forming pH-sensitive nanoparticles for nucleic acid delivery. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[92]  E. Wagner,et al.  Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. , 2008, Bioconjugate chemistry.

[93]  S. Hart,et al.  Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[94]  H. Mizusawa,et al.  High-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brain. , 2011, Human gene therapy.

[95]  M. Ogris,et al.  Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. , 2009, Molecular pharmaceutics.

[96]  Leaf Huang,et al.  Gene therapy progress and prospects: non-viral gene therapy by systemic delivery , 2006, Gene Therapy.

[97]  A. Verkman,et al.  Actin Cytoskeleton as the Principal Determinant of Size-dependent DNA Mobility in Cytoplasm , 2005, Journal of Biological Chemistry.

[98]  E. Wagner,et al.  Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. , 2008, Journal of the American Chemical Society.

[99]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[100]  C. Pichon,et al.  Chemical vectors for gene delivery: uptake and intracellular trafficking. , 2010, Current opinion in biotechnology.

[101]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[102]  Suzie H Pun,et al.  Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. , 2008, Bioconjugate chemistry.

[103]  T. Andresen,et al.  Revisit complexation between DNA and polyethylenimine--effect of length of free polycationic chains on gene transfection. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[104]  C. Culmsee,et al.  Targeting of polyplexes: toward synthetic virus vector systems. , 2005, Advances in genetics.

[105]  Leaf Huang,et al.  Surface‐Modified LPD Nanoparticles for Tumor Targeting , 2006, Annals of the New York Academy of Sciences.

[106]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[107]  Jean-Paul Behr,et al.  Sticky overhangs enhance siRNA-mediated gene silencing , 2007, Proceedings of the National Academy of Sciences.

[108]  J. Kjems,et al.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity , 2009, Nucleic acids research.

[109]  O. Zelphati,et al.  Stable and monodisperse lipoplex formulations for gene delivery , 1998, Gene Therapy.

[110]  T. Rana,et al.  siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.

[111]  T. Park,et al.  Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing. , 2011, Bioconjugate chemistry.

[112]  T. Kissel,et al.  Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. , 2006, Bioconjugate chemistry.

[113]  Erwin Frey,et al.  Predictive modeling of non‐viral gene transfer , 2010, Biotechnology and bioengineering.

[114]  M. Gumbleton,et al.  Polylysine and Polyornithine Gene Transfer Complexes: A Study of Complex Stability and Cellular Uptake as a Basis for their Differential in-vitro Transfection Efficiency , 2002, Journal of drug targeting.

[115]  Mark E. Davis,et al.  Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging , 2006, Nucleic acids research.

[116]  N. Svrzikapa,et al.  Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.